Logo

ASTM D5022-07

Current Revision

Standard Specification for Identification of Vials and Ampoules Containing Concentrated Solutions of Drugs to be Diluted Before Use (Withdrawn 2014)

$73.00

$73.00

$131.40


Sub Total (1 Item(s))

$ 0.00

Estimated Shipping

$ 0.00

Total (Pre-Tax)

$ 0.00


Document Preview Not Available...

1.1 This specification deals with identification of small volume containers of drugs intended to be diluted before parenteral administration, as follows:

1.1.1 Container shape,

1.1.2 Labeling statements.

1.1.3 Vial closures and Flip-Off, type caps, and

1.1.4 Ampoule marking.


This specification deals with identification of small volume containers of drugs intended to be diluted before parenteral administration such as container shape, labeling statements, vial closures and ampoule marking. Drugs in liquid form requiring dilution before parenteral administration shall not be packaged in containers that resemble a normal syringe. The design of such containers shall preclude direct intravenous line injection of the solution. The labels on each container shall bear the words dilute before use. Such black metal closures and black flip-off type caps and use of a black band or series of bands above the contracture on an ampoule shall only be used for Potassium Chloride for Injection Concentrate. With this, identification of such vials and ampoules shall be easy.


SDO ASTM: ASTM International
Document Number D5022
Publication Date Oct. 1, 2007
Language en - English
Page Count 2
Revision Level 07
Supercedes
Committee D10.32
Publish Date Document Id Type View
Oct. 1, 2007 D5022-07 Revision
Sept. 15, 1995 D5022-95 Revision
Sept. 15, 1995 D5022-95R01 Reaffirmation